Labcorp Holdings Inc. (LH) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in Burlington, NC, United States. The current CEO is Adam H. Schechter.
LH has IPO date of 1990-03-29, 60,900 full-time employees, listed on the NYSE, a market capitalization of $22.29B.
Labcorp Holdings Inc. is a global life sciences company that provides diagnostic testing and drug development services to support healthcare decision-making for doctors, hospitals, pharmaceutical companies, researchers, and patients. Operating through two main segments—Labcorp Diagnostics and Labcorp Drug Development—the company offers a comprehensive range of laboratory tests including blood chemistry, urinalysis, genetic testing, specialty diagnostics for diseases such as cancer and cardiovascular conditions, and occupational health services. Beyond diagnostics, Labcorp provides end-to-end drug development solutions, medical device testing, and companion diagnostic services from early-stage research through commercial market access. The company serves a diverse clientele including managed care organizations, pharmaceutical and biotechnology companies, hospitals, employers, and individual patients through both traditional laboratory services and digital platforms. Labcorp is committed to advancing clinical trial diversity and improving healthcare access across multiple patient populations.
